Id |
Subject |
Object |
Predicate |
Lexical cue |
T235 |
11-16 |
NN |
denotes |
PBMCs |
T236 |
17-21 |
IN |
denotes |
from |
T237 |
22-24 |
NN |
denotes |
CF |
T238 |
25-33 |
NN |
denotes |
patients |
T239 |
34-37 |
CC |
denotes |
and |
T240 |
38-46 |
NN |
denotes |
controls |
T241 |
47-56 |
VB |
denotes |
displayed |
T242 |
57-64 |
JJ |
denotes |
similar |
T243 |
65-71 |
NN |
denotes |
levels |
T244 |
72-74 |
IN |
denotes |
of |
T245 |
75-84 |
NN |
denotes |
caspase-1 |
T246 |
85-95 |
NN |
denotes |
activation |
T247 |
96-99 |
CC |
denotes |
and |
T248 |
100-105 |
NN |
denotes |
IL-1β |
T249 |
106-116 |
NN |
denotes |
production |
T250 |
117-121 |
WRB |
denotes |
when |
T251 |
122-132 |
VB |
denotes |
stimulated |
T252 |
133-137 |
IN |
denotes |
with |
T253 |
138-150 |
JJ |
denotes |
inflammasome |
T254 |
151-161 |
NN |
denotes |
activators |
T255 |
163-167 |
DT |
denotes |
This |
T256 |
168-173 |
NN |
denotes |
IL-1β |
T257 |
174-184 |
NN |
denotes |
production |
T258 |
185-188 |
VB |
denotes |
was |
T259 |
189-198 |
JJ |
denotes |
dependent |
T260 |
199-201 |
IN |
denotes |
on |
T261 |
202-207 |
NN |
denotes |
NF-κB |
T262 |
208-216 |
NN |
denotes |
activity |
T263 |
217-220 |
CC |
denotes |
and |
T264 |
221-226 |
MD |
denotes |
could |
T265 |
227-229 |
VB |
denotes |
be |
T266 |
230-238 |
VB |
denotes |
enhanced |
T267 |
239-241 |
IN |
denotes |
by |
T268 |
242-249 |
VB |
denotes |
priming |
T269 |
250-254 |
IN |
denotes |
with |
T270 |
255-258 |
NN |
denotes |
LPS |
T271 |
260-267 |
RB |
denotes |
Finally |
T272 |
267-268 |
-COMMA- |
denotes |
, |
T273 |
269-277 |
JJ |
denotes |
chemical |
T274 |
278-288 |
NN |
denotes |
inhibition |
T275 |
289-291 |
IN |
denotes |
of |
T276 |
292-296 |
NN |
denotes |
CFTR |
T277 |
297-305 |
NN |
denotes |
activity |
T278 |
306-308 |
IN |
denotes |
in |
R186 |
T235 |
T236 |
arg1Of |
PBMCs,from |
R187 |
T235 |
T241 |
arg1Of |
PBMCs,displayed |
R188 |
T238 |
T237 |
arg1Of |
patients,CF |
R189 |
T238 |
T239 |
arg1Of |
patients,and |
R190 |
T239 |
T236 |
arg2Of |
and,from |
R191 |
T240 |
T239 |
arg2Of |
controls,and |
R192 |
T241 |
T250 |
arg1Of |
displayed,when |
R193 |
T243 |
T241 |
arg2Of |
levels,displayed |
R194 |
T243 |
T242 |
arg1Of |
levels,similar |
R195 |
T243 |
T244 |
arg1Of |
levels,of |
R196 |
T246 |
T245 |
arg1Of |
activation,caspase-1 |
R197 |
T246 |
T247 |
arg1Of |
activation,and |
R198 |
T247 |
T244 |
arg2Of |
and,of |
R199 |
T249 |
T247 |
arg2Of |
production,and |
R200 |
T249 |
T248 |
arg1Of |
production,IL-1β |
R201 |
T251 |
T250 |
arg2Of |
stimulated,when |
R202 |
T251 |
T252 |
arg1Of |
stimulated,with |
R203 |
T254 |
T252 |
arg2Of |
activators,with |
R204 |
T254 |
T253 |
arg1Of |
activators,inflammasome |
R205 |
T257 |
T255 |
arg1Of |
production,This |
R206 |
T257 |
T256 |
arg1Of |
production,IL-1β |
R207 |
T257 |
T258 |
arg1Of |
production,was |
R208 |
T257 |
T259 |
arg1Of |
production,dependent |
R209 |
T257 |
T264 |
arg1Of |
production,could |
R210 |
T257 |
T265 |
arg1Of |
production,be |
R211 |
T257 |
T266 |
arg2Of |
production,enhanced |
R212 |
T258 |
T263 |
arg1Of |
was,and |
R213 |
T259 |
T258 |
arg2Of |
dependent,was |
R214 |
T259 |
T260 |
arg1Of |
dependent,on |
R215 |
T262 |
T260 |
arg2Of |
activity,on |
R216 |
T262 |
T261 |
arg1Of |
activity,NF-κB |
R217 |
T266 |
T263 |
arg2Of |
enhanced,and |
R218 |
T266 |
T264 |
arg2Of |
enhanced,could |
R219 |
T266 |
T265 |
arg2Of |
enhanced,be |
R220 |
T266 |
T267 |
arg1Of |
enhanced,by |
R221 |
T268 |
T267 |
arg2Of |
priming,by |
R222 |
T268 |
T269 |
arg1Of |
priming,with |
R223 |
T270 |
T269 |
arg2Of |
LPS,with |
R224 |
T274 |
T273 |
arg1Of |
inhibition,chemical |
R225 |
T274 |
T275 |
arg1Of |
inhibition,of |
R226 |
T274 |
T278 |
arg1Of |
inhibition,in |
R229 |
T277 |
T275 |
arg2Of |
activity,of |
R230 |
T277 |
T276 |
arg1Of |
activity,CFTR |